The new standard of HCV therapy: Retreatment in experienced patients

Authors

  • Naveen Gara M.D.,

    1. From the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD
    Search for more papers by this author
  • Marc G. Ghany M.D., M.H.Sc.

    Corresponding author
    1. From the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD
    • Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive, Building 10, Room 9B-16, MSC 1800, Bethesda, MD 20892-1800
    Search for more papers by this author
    • Fax: 301-402-0491.


  • This research was supported by the Intramural Research Programs of the National Institute of Diabetes and Digestive and Kidney Diseases and the National Cancer Institute (National Institutes of Health).

  • Potential conflict of interest: Nothing to report

Abstract

Watch the interview with the authors

Watch the video presentation of this article

Answer questions and earn CME

Ancillary